# Axillary Reverse Mapping Using Methylene Blue Subcutaneous Injection Can Identify Arm Lymph Nodes and Vessels, Measuring Arm Size for Lymphedema, Histopathological Examination of Arm Lymph Nodes Included With Axillary Lymph Node Dissection

> **NCT04137744** · NA · COMPLETED · sponsor: **Zagazig University** · enrollment: 74 (actual)

## Conditions studied

- Arm Lymphedema
- Lymphatic Spread of Breast Cancer
- Early Breast Cancer

## Interventions

- **PROCEDURE:** AXILLARY REVERSE MAPPING

## Key facts

- **NCT ID:** NCT04137744
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2019-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04137744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04137744, "Axillary Reverse Mapping Using Methylene Blue Subcutaneous Injection Can Identify Arm Lymph Nodes and Vessels, Measuring Arm Size for Lymphedema, Histopathological Examination of Arm Lymph Nodes Included With Axillary Lymph Node Dissection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04137744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*